Citations

Showing 10 of 108104 citations.

Creating a New Set of Milestones for the Clinical Neurophysiology Fellowship
Albert, Dara V. F. , Hanrahan, Brian J., Felker, Marcia V., Nguyen, Thy P., Jones, Lyell K., Freedman, Daniel A., Pawar, Gauri V., Danner, Nicole, Singhal, Divya, McLean, Sydney M., Edgar, Laura A., Albert, Dara V. F. , Hanrahan, Brian J., Felker, Marcia V., Nguyen, Thy P., Jones, Lyell K., Freedman, Daniel , Pawar, Gauri V., Danner, Nicole, Singhal, Divya, McLean, Sydney M., Edgar, Laura A.

Mayo Clinic

Journal of Clinical Neurophysiology | March 3, 2022 | Volume: 39 | Issue: 4 | Pages: 265-270

10.1097/wnp.0000000000000932 | PMID 35239552 Get It

Introduction: The Accreditation Council for Graduate Medical Education and the American Board of Psychiatry and Neurology first developed milestones for the clinical neurophysiology (CNP) fellowship in 2015. The milestones provide a comprehensive evaluation of the fellow's development based on six domains of competency. Here, we describe the development of a new set of milestones for CNP fellowship with level 1 as the incoming level, level 4 as the goal for graduation, and level 5 as the aspirational level that may not be achieved. Methods: Committee members were nominated or volunteered to participate in the milestones update. Milestone development began with the creation of a shared mental model of the ideal skills and knowledge a graduating CNP fellow should attain. Results: The CNP committee met virtually 7 times for a total of 14 meeting hours. Nine Patient Care and five Medical Knowledge milestones evolved from the seven Patient Care and six Medical Knowledge milestones that were in the first iteration. The committee incorporated 11 “Harmonized Milestones” into the revision and a supplemental guide was created. Conclusions: The revised Accreditation Council for Graduate Medical Education milestones for CNP fellowship contain important updates that program directors should review against their curricula to identify any gaps in learning. Program leadership should take note of two new Patient Care milestones for telemedicine and intraoperative monitoring. Clinical neurophysiology fellowships are not designed to provide level 4 competency across all milestones. The revised milestones should be viewed within the context of an individual program's goals.
Defining Success after Anterior Urethroplasty: An Argument for a Universal Definition and Surveillance Protocol
Anderson, Katherine T. , Vanni, Alex J. , Erickson, Bradley A. , Broghammer, Joshua A. , Buckley, Jill C. , Smith, Thomas G. , Alsikafi, Nejd F. , Elliott, Sean P. , Myers, Jeremy B. , Voelzke, Bryan B. , Breyer, Benjamin N. , Zhao, Lee C. , Rourke, Keith Francis

Mayo Clinic

Journal of Urology | March 3, 2022 | Volume: 208 | Issue: 1 | Pages: 135-143

10.1097/ju.0000000000002501 | PMID 35239415 Get It

Commentary: The Legal and Socioeconomic Considerations in Spine Telemedicine
Bydon, Mohamad , Michalopoulos, Giorgos D. , Michalopoulos, Giorgos , Bydon, Mohamad

Mayo Clinic

Neurosurgery | March 3, 2022 | Volume: 90 | Issue: 5 | Pages: e125-e126

10.1227/neu.0000000000001918 | PMID 35238811 Get It

Retrospective evaluation of operator bias in the performance of high‐resolution anorectal manometry
Prichard, David O. , Fetzer, Jeffrey , Fetzer, Jeffrey R

Mayo Clinic

Neurogastroenterology & Motility | March 3, 2022 | Volume: 34 | Issue: 9 | Pages: No page available

10.1111/nmo.14341 | PMID 35238445 Get It

AbstractBackgroundMeasurements obtained during high‐resolution anorectal manometry (HRM) are subject to operator–patient interactions. For example, standardized enhanced instruction delivered by a single operator in a test–retest fashion did not consistently increase pressures generated during dynamic maneuvers. It is probable that factors other than verbal instruction effect communication during the procedure. To investigate this hypothesis, we retrospectively examined inter‐operator variance in HRM results.MethodsThe electronic health records at Mayo Clinic, Rochester, were used to identify patients who had undergone HRM in 2019 and 2020. The analysis focused on constipated patients. The instructions given to the patients they had examined, and the pressure measurements obtained during HRM, by 6 different nurse operators were compared.Key ResultsWhen performing HRM on their individual patients (range 126–673), the 6 nurses used similar instructions for each of the maneuvers and sensory testing thresholds. The proportion of patients with prolonged balloon expulsion tests and the rectal sensory thresholds were similar among operators. Significant variance was seen in the mean rectoanal pressures at rest, during squeeze, and during dynamic maneuvers. The proportion of patients with manometry results suggestive of a defecatory disorder differed between operators by 18% and 28% in women <50 and >50 years old, respectively.Conclusions & InferencesOperators obtain significantly different results during HRM despite using similar instructions to patients. Substantial differences in the proportion of patients with manometry findings suggestive of a defecatory disorder among operators may have a significant impact on the diagnoses and therapies offered to constipated patients.
Diagnosis and Treatment of ERBB2-Positive Metastatic Colorectal Cancer
Bekaii‐Saab, Tanios , Bekaii-Saab, Tanios S , Strickler, John H. , Yoshino, Takayuki , Graham, Rondell P. , Siena, Salvatore

Mayo Clinic

JAMA Oncology | March 3, 2022 | Volume: 8 | Issue: 5 | Pages: 760

10.1001/jamaoncol.2021.8196 | PMID 35238866 Get It

Carotid artery endarterectomy in patients with symptomatic non-stenotic carotid artery disease
Nardi, Valentina , Larson, Anthony S. , Brinjikji, Waleed , Saba, Luca , Meyer, Fredric B. , Lerman, Amir , Benson, John C. , Larson, Anthony , Lerman, Amir , Savastano, Luis E., Nardi, Valentina , Saba, Luca , Lanzino, Giuseppe , Savastano, Luis

Mayo Clinic

Stroke and Vascular Neurology | March 3, 2022 | Volume: 7 | Issue: 3 | Pages: 251-257

10.1136/svn-2021-000939 | PMID 35241631 Get It

Object We sought to determine the safety and efficacy in secondary stroke prevention of carotid endarterectomy (CEA) in patients with symptomatic non-stenotic carotid artery disease (SyNC). Methods This was a single-centre retrospective case series. All patients who underwent CEA for unilateral anterior circulation cerebrovascular events with ipsilateral <50% carotid stenosis from 2002 to 2020 were included. Imaging hallmarks including the degree of luminal stenosis and the presence of various vulnerable plaque characteristics (eg, intraplaque haemorrhage (IPH) on MR angiography, ulceration or low-density plaque on CT angiography) were assessed. The presence of vulnerable plaque characteristics was compared between arteries ipsilateral to the ischaemic event and contralateral arteries. The prevalence of perioperative/intraoperative complications, as well as recurrent ischaemic events at follow-up was determined. Results Thirty-two patients were included in the analysis, of which 25.0% were female. Carotid arteries ipsilateral to an ischaemic event had a significantly higher prevalence of IPH when compared with contralateral arteries (80.0% vs 0.0%; p<0.001). There were no intraoperative complications. One patient (3.1%) developed symptoms of transient ipsilateral ischaemia 1 day following CEA which resolved without treatment. In a median follow-up of 18.0 months (IQR 5.0–36.0), only one patient (3.1%) experienced a transient neurologic deficit with complete resolution (annualised rate of recurrent stroke after CEA of 1.5% for a total follow-up of 788 patient-months following CEA). All other patients (31/32, 96.9%) were free of recurrent ischaemic events. Conclusion CEA appears to be safe and well-tolerated in patients with SyNC. Additional studies with larger cohorts and longer follow-up intervals are needed in order to determine the role of CEA in this patient population.
A pilot study of vidofludimus calcium for treatment of primary sclerosing cholangitis
Carey, Elizabeth J. , Eaton, John E. , Clayton, Mitchell, Gossard, Andrea A., Iqbal, Sara , Zhang, Nan , Butterfield, Richard , Lindor, Keith D. , Eaton, John, Gossard, Andrea, Iqbal, Sara, Ullah, Hamid

Mayo Clinic

Hepatology Communications | March 3, 2022 | Volume: 6 | Issue: 7 | Pages: 1589-1597

10.1002/hep4.1926 | PMID 35238498 Get It

Abstract The purpose of this pilot study was to explore the efficacy, safety, and tolerability of vidofludimus calcium (VC) in the treatment of primary sclerosing cholangitis (PSC). This was a single‐arm open‐label pilot study with a cohort of 18 patients with PSC. Study patients received VC for a period of 6 months. The study was undertaken at two sites, Mayo Clinic, Rochester, MN, and Mayo Clinic, Phoenix, AZ. The primary endpoint of the study was improvement of serum alkaline phosphatase (ALP) at the end of the study. Secondary endpoints included assessment of other liver biomarkers (bilirubin, alanine aminotransferase, and aspartate aminotransferase). Of 18 patients enrolled, 11 completed the 6 months of study treatment. Patients who completed treatment versus those who did not were similar other than a significantly higher direct bilirubin at baseline in the group that completed treatment (mean ± SD, 0.4 ± 0.3 versus 0.1 ± 0.1, p = 0.04). By intent to treat analysis, the primary outcome was met in 16.7% (3/18) of patients. By per‐protocol analysis, including only patients who completed treatment, normalization of ALP occurred in 27.7% (3/11) at week 24 (95% confidence interval, 6.0% to 61.0%). VC was well tolerated with no drug‐related serious adverse events. Conclusion: This proof of concept study provides support for further exploration of VC in patients with PSC.
The Impact of Radiation Dose to Heart Substructures on Major Coronary Events and Patient Survival after Chemoradiation Therapy for Esophageal Cancer
Wang, Xin , Hobbs, Brian P. , Nead, Kevin T. , Yusuf, Syed Wamique , Hermann, Joerg, Lin, Steven H. , Lin, Steven H , Palaskas, Nicolas L , Abe, Jun-Ichi , Yusuf, Syed Wamique , Deswal, Anita M

Mayo Clinic

Cancers | March 3, 2022 | Volume: 14 | Issue: 5 | Pages: 1304

10.3390/cancers14051304 | PMID 35267613 Get It

Background: There is a paucity of data regarding the association between radiation exposure of heart substructures and the incidence of major coronary events (MCEs) in patients with esophageal cancer (ESOC) undergoing chemoradiation therapy. We studied radiation dosimetric determinants of MCE risk and measured their impact on patient prognosis using a cohort of ESOC patients treated at a single institution. Methods: Between March 2005 and October 2015, 355 ESOC patients treated with concurrent chemoradiotherapy were identified from a prospectively maintained and institutional-regulatory-board-approved clinical database. Dose-distribution parameters of the whole heart, the atria, the ventricles, the left main coronary artery, and three main coronary arteries were extracted for analysis. Results: Within a median follow-up time of 67 months, 14 patients experienced MCEs at a median of 16 months. The incidence of MCEs was significantly associated with the left anterior descending coronary artery (LAD) receiving ≥30 Gy (V30Gy) (p = 0.048). Patients receiving LAD V30Gy ≥ 10% of volume experienced a higher incidence of MCEs versus the LAD V30Gy < 10% group (p = 0.044). The relative rate of death increased with the left main coronary artery (LMA) mean dose (Gy) (p = 0.002). Furthermore, a mutual promotion effect of hyperlipidemia and RT on MCEs was observed. Conclusion: Radiation dose to coronary substructures is associated with MCEs and overall survival in patients with ESOC. In this study, the doses to these substructures appeared to be better predictors of toxicity outcomes than mean heart dose (MHD) or whole-heart V30Gy. These findings have implications for reducing coronary events through radiation therapy planning.
Gastrointestinal Microbiome Disruption and Antibiotic-Associated Diarrhea in Children Receiving Antibiotic Therapy for Community-Acquired Pneumonia
Kong, Yong , Wade, Martina , Williams, Derek J. , Creech, C. Buddy , Walter, Emmanuel B. , Martin, Judy M, Gerber, Jeffrey S. , Newland, Jason G. , Hofto, Meghan E. , Staat, Mary Allen , Chambers, Henry F. , Fowler, Vance G. , Pettigrew, Melinda M. , Pettigrew, M M , Evans, Scott R , Staat, Mary A , Kwon, Jiye , Evans, Scott , Fowler, Vance G. , Huskins, W. Charles

Mayo Clinic

The Journal of Infectious Diseases | March 2, 2022 | Volume: 226 | Issue: 6 | Pages: 1109-1119

10.1093/infdis/jiac082 | PMID 35249113 Get It

Abstract Antibiotic-associated diarrhea (AAD) is a common side effect of antibiotics. We examined the gastrointestinal microbiota in children treated with β-lactams for community-acquired pneumonia. Data were from 66 children (n = 198 samples), aged 6–71 months, enrolled in the SCOUT-CAP trial (NCT02891915). AAD was defined as ≥1 day of diarrhea. Stool samples were collected on study days 1, 6–10, and 19–25. Samples were analyzed using 16S ribosomal RNA gene sequencing to identify associations between patient characteristics, microbiota characteristics, and AAD (yes/no). Nineteen (29%) children developed AAD. Microbiota compositional profiles differed between AAD groups (permutational multivariate analysis of variance, P &lt; .03) and across visits (P &lt; .001). Children with higher baseline relative abundances of 2 Bacteroides species were less likely to experience AAD. Higher baseline abundance of Lachnospiraceae and amino acid biosynthesis pathways were associated with AAD. Children in the AAD group experienced prolonged dysbiosis (P &lt; .05). Specific gastrointestinal microbiota profiles are associated with AAD in children.
Can Exercise Training Alter Human Skeletal Muscle DNA Methylation?
Bustos, Rocio Zapata , Campos, Baltazar, Hamzaoui, Yassin , Leon, Alma D., Krentzel, Judith, Coletta, Richard L., Filippis, Eleanna De , Roust, Lori R., Mandarino, Lawrence J. , Coletta, Dawn K. , Hamzaoui, Yassin , De Filippis, Eleanna, Coletta, Dawn K , Garcia, Luis Alberto , Day, Samantha E. , Wu, Linda

Mayo Clinic

Metabolites | March 2, 2022 | Volume: 12 | Issue: 3 | Pages: 222

10.3390/metabo12030222 | PMID 35323665 Get It

Skeletal muscle is highly plastic and dynamically regulated by the body’s physical demands. This study aimed to determine the plasticity of skeletal muscle DNA methylation in response to 8 weeks of supervised exercise training in volunteers with a range of insulin sensitivities. We studied 13 sedentary participants and performed euglycemic hyperinsulinemic clamps with basal vastus lateralis muscle biopsies and peak aerobic activity (VO2 peak) tests before and after training. We extracted DNA from the muscle biopsies and performed global methylation using Illumina’s Methylation EPIC 850K BeadChip. Training significantly increased peak aerobic capacity and insulin-stimulated glucose disposal. Fasting serum insulin and insulin levels during the steady state of the clamp were significantly lower post-training. Insulin clearance rates during the clamp increased following the training. We identified 13 increased and 90 decreased differentially methylated cytosines (DMCs) in response to 8 weeks of training. Of the 13 increased DMCs, 2 were within the following genes, FSTL3, and RP11-624M8.1. Of the 90 decreased DMCs, 9 were within the genes CNGA1, FCGR2A, KIF21A, MEIS1, NT5DC1, OR4D1, PRPF4B, SLC26A7, and ZNF280C. Moreover, pathway analysis showed an enrichment in metabolic and actin-cytoskeleton pathways for the decreased DMCs, and for the increased DMCs, an enrichment in signal-dependent regulation of myogenesis, NOTCH2 activation and transmission, and SMAD2/3: SMAD4 transcriptional activity pathways. Our findings showed that 8 weeks of exercise training alters skeletal muscle DNA methylation of specific genes and pathways in people with varying degrees of insulin sensitivity.